Key facts
- This page summarizes Glenn Frank Short's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Mar 2025, 21:00.
Glenn Frank Short - 21 Mar 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- ATAI
- Reported as of
- 21 Mar 2025
- Net transaction value
- -$17,767
- SEC form
- 4
- Accepted by SEC
- 24 Mar 2025, 21:00:05 UTC
- Prior SEC filing
- 19 Mar 2025
- Next SEC filing
- 03 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan Barrett, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Glenn Frank Short filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 24 Mar 2025.
Change
- Previous filing in this sequence was filed on 19 Mar 2025.
- Current net transaction value: -$17,767.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATAI
transaction
Common Shares
Sale
- Transaction value
- $17,767
- Shares
- -13,161
- Change %
- -24%
- Price
- $1.35
- Shares after
- 42,333
- Date
- 21 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.